featured
Modified Docetaxel, Cisplatin, and Fluorouracil for Metastatic Gastric Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium
J. Clin. Oncol 2015 Oct 14;[EPub Ahead of Print], MA Shah, YY Janjigian, R Stoller, S Shibata, M Kemeny, S Krishnamurthi, YB Su, A Ocean, M Capanu, B Mehrotra, P Ritch, C Henderson, DP KelsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.